Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • T vs MRNA✓SelectedUSD · MRNAT vs MRNA performance historyLatest closeAs of-0.46%11/19
Stock and ETF performance explorer

T vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-10.4%
MRNA return
+318.7%
Excess return
-329.0%
Maximum drawdown
-21.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 6mo.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-0.5%+1.3%-1.7%-0.4%
7D-1.5%-13.8%+12.4%-1.6%
30D-6.7%-17.7%+11.0%-6.8%
3M-12.0%+14.3%-26.3%-12.0%
6M-10.4%+336.0%-346.3%-2.3%
All-10.4%+318.7%-329.0%-2.3%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 6mo: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

6mo analysis · Full analysis span regression · 6 months rolling